7-bromo-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-1-one

ID: ALA1092831

PubChem CID: 46883813

Max Phase: Preclinical

Molecular Formula: C10H7BrN2O

Molecular Weight: 251.08

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CCc2nc3ccc(Br)cc3n21

Standard InChI:  InChI=1S/C10H7BrN2O/c11-6-1-2-7-8(5-6)13-9(12-7)3-4-10(13)14/h1-2,5H,3-4H2

Standard InChI Key:  KSVJMBNUZJAOSQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 16  0  0  0  0  0  0  0  0999 V2000
   13.5750    1.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9875    2.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3224    2.3299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6568    2.3299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4000    1.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0664    1.0592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9862    3.6417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4775    2.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7379    1.5424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5467    1.3766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0958    1.9952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8306    2.7824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0225    2.9445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3758    3.4016    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  8  4  1  0
  2  3  1  0
  2  7  2  0
  3  1  1  0
  4  5  1  0
  8  9  2  0
  1  5  1  0
  9 10  1  0
 10 11  2  0
  4  2  1  0
 11 12  1  0
  5  6  2  0
 12 13  2  0
 13  8  1  0
  6  9  1  0
 12 14  1  0
M  END

Alternative Forms

Associated Targets(Human)

SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 251.08Molecular Weight (Monoisotopic): 249.9742AlogP: 2.39#Rotatable Bonds:
Polar Surface Area: 34.89Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.10CX LogP: 1.52CX LogD: 1.52
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.72Np Likeness Score: -0.95

References

1. Sondhi SM, Rani R, Singh J, Roy P, Agrawal SK, Saxena AK..  (2010)  Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.,  20  (7): [PMID:20188544] [10.1016/j.bmcl.2010.01.147]

Source